Coronary artery disease and arterial hypertension: Clinical, angiographic and follow-up data

Journal of Internal Medicine

Volumn 247, Issue 2, 2000, Pages 219-230

  Natali, A ^a,b   Vichi, S ^a   Landi, P ^a   Toschi, E ^a   Severi, S ^a   L'Abbate, A ^a   Ferrannini, E ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Atherosclerosis; Coronary artery disease; Hypertension

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADULT; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MEDICAL RECORDS; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 0033975645     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00637.x     Document Type: Article

References (38)

1. 1 MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke and coronary heart disease, part I: effect of prolonged differences in blood pressure - evidence from nine prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
2. 2 Collins R, Peto R, MacMahon S et al. Blood pressure, stroke and coronary heart disease, part II: effects of short-term reductions in blood pressure - an overiew of the unconfounded randomized drug trials in an epidemiological context. Lancet 1990; 335: 827-38.
3. 3 Bronte-Stewart B, Heptinstall RH. The relationship between experimental hypertension and cholesterol-induced atheroma in rabbits. J Pathol Bact 1954; 68: 407-12.
4. 4 Moses C. Development of atherosclerosis in dogs with hypercholesterolemia and chronic hypertension. Circ Res 1954; 2: 243.
5. 5 Walkerin GE, Moss WG, Kiely JP. Effect of experimental renal hypertension on experimental thiouracil-cholesterol atherosclerosis in dogs. Circ Res 1957; 5: 426-34.
6. 6 Armstrong ML, Warner ED, Couner WE. Regression of coronary atheromatosis in rhesus monkeys. Circ Res 1970; 27: 59-67.
7. 7 Salonen R, Salonen JT. Carotid atherosclerosis in relation to systolic and diastolic blood pressure: Kuopio Ischemie Heart Disease Risk Factor Study. Ann Med 1991; 23: 23-27.
8. 8 Roberts WC. Frequency of systemic hypertension in various cardiovascular diseases. Am J Cardiol 1987; 60: 1-8E.
9. 9 Roberts WC. Preventing and arresting coronary atherosclerosis. Am Heart J 1995; 130: 580-600.
10. 10 Wilkins RH, Roberts JC Jr, Moses C. Autopsy studies in atherosclerosis. III. Distribution and severity of atherosclerosis in the presence of obesity, hypertension, nephrosclerosis and rheumatic heart disease. Circulation 1959; 20: 527-34.
11. 11 Davis D, Klainer MJ. Studies in hypertensive heart disease. I. The incidence of coronary atherosclerosis in essential hypertension. Am Heart J 1940; 19: 185-92.
12. 12 Robertson WB, Strong JP. Atherosclerosis in person with hypertension and diabetes mellitus. Lab Invest 1968; 16: 538-51.
13. 13 De Cesare N, Polese A, Cozzi S et al. Coronary angiographic patterns in hypertensive compared with normotensive patients. Am Heart J 1991; 121: 1101-106.
14. 14 French JK, Elliot JM, Williams BF, Nixon DJ, Denton MA, White HD. Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension. Am J Cardiol 1993; 71: 505-10.
15. 15 Sanchez Torres G, Posadas Romero C, Tena Tamayo C, Hernandez Santamaria I. Systemic arterial hypertension and coronary atherosclerosis. Observations in survivors of a first myocardial infarction. Drugs 1988; 35: 111-17.
16. 16 Doyle AE. Does hypertension predispose to coronary disease? Conflicting epidemiological and experimental evidence. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. New York: Raven Press, 1995; 57-66.
17. 17 Opherk D, Mall G, Zebe H et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69: 1-7.
18. 18 Pichard AD, Gorun R, Smith H, Ambrose J. Meller J. Coronary flow studies in patients of left ventricular hypertrophy of the hypertensive type. Evidence of an impaired coronary vascular reserve. Am J Cardiol 1981; 47: 547-54.
19. 19 Brush JE, Cannon RO, IIISchenke WH et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302-307.
20. 20 Dunn F, Pringle S. Left ventricular hypertrophy and myocardial ischemia in systemic hypertension. Am J Cardiol 1987; 60: 191-221.
21. 21 Levy N, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-66.
22. 22 Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: Diabetes in America, 2nd edn. NIH publication no. 95-1468, National Institutes of Diabetes and Digestive and Kidney Diseases, 1995; 429-48.
23. 23 Severi S, Picano E, Michelassi C et al. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography. Circulation 1994; 89: 1160-73.
24. 24 Rowe GG, Thomsen JH, Sternlund RR, McKenna DH, Sialer S, Corliss RJ. A study of hemodynamics and coronary blood flow in man with coronary artery disease. Circulation 1969; 39: 139-48.
25. 25 SAS Institute, Inc. JMP Statistics and Graphics Guide, Version 3.1. Cary, NC, USA: SAS Institute Inc., 1995.
26. 26 Laurenzi M, Mancini M, Menotti A et al. Multiple risk factors in hypertension: results from the Gubbio Study. J Hypertens 1990; 8: S7-12.
27. 27 Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-22.
28. 28 Nilsson P, Lindholm L, Schersten B. Hyperinsulinemia and other metabolic disturbances in well-controlled hypertensive men and women: and epidemiological study of the dalby population. J Hypertens 1990; 8: 953-59.
29. 29 Ferrannini E, Natali A. Hypertension, insulin resistance, and diabetes. In: Swales JD, ed. Textbook of Hypertension. Chichester: Blackwell Scientific Publications, 1994; 785-97.
30. 30 Devereux RB, Roman MJ. Hypertensive cardiac hypertrophy: pathophysiologic and clinical characteristics. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. New York: Raven Press, 1995.
31. 31 Messer AL, Jhonson RP, Shreenivas White PD. Prognosis in bundle block. III. A comparison of right and left bundle block with a note on the relative incidence of each. Am Heart J 1951; 41: 239-45.
32. 32 Johnson RP, Messer AL, Shreenivas White PD. Prognosis in bundle block. II. Factors influencing the survival period in left bundle block. Am Heart J 1951; 41: 225-38.
33. 33 Schneider JF, Thomas HE Jr, Sorlie P, Kreger BE, McNamara PM, Kannel WB. Comparative features of newly acquired left and right bundle branch block in the general population: the Framingham study. Am J Cardiol 1981; 47: 931-40.
34. 34 Wilson PWF, Kannel WB. Hypertension, other risk factors, and the risk of cardiovascular disease. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. New York: Raven Press, 1995: 99-114.
35. 35 Fumeron F, Betoulle D, Luc G et al. Alcohol intake modulates the effect of a polymorphysm of the colesleryl ester transfer protein gene on plasma high density lipoprotcin and risk of myocardial infarction. J Clin Invest 1995; 96: 1664-71.
36. 36 Gaziano JM, Buring JE, Breslow JL et al. Moderate alcohol intake, increased level of high-density lipoprotein subfractions and decreased risk of myocardial infarction. N Engl J Med 1993; 329: 1829-34.
37. 37 Handa K, Sasaki J, Saku K, Kono S, Arakawa K. Alcohol consumption, serum lipids and severity of angiographically determined coronary artery disease. Am J Cardiol 1990; 65: 287-89.
38. 38 Williams RR, Hunt SC, Hopkuins PM et al. Familial dyslipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. J Am Meet Assoc 1988; 259: 3579-86.